Beta
Maralixibat
medication Under reviewAn ileal bile acid transporter (IBAT) inhibitor used to treat itching caused by Alagille syndrome and progressive familial intrahepatic cholestasis.
Research summary
Scientific evidence for maralixibat centers on its use in pediatric populations with cholestatic liver diseases like Alagille syndrome and progressive familial intrahepatic cholestasis, where it demonstrates reductions in pruritus severity and serum bile acids. No studies were identified involving healthy human subjects, limiting applicability to general wellness or supplementation in healthy individuals. Research consensus supports its safety and tolerability in diseased populations, with minor gastrointestinal side effects reported.
No side effects tracked yet
No side effects have been reported by studies or users for this habit yet.
Research
No studies found yet. Request research to discover relevant studies.
Community updates
No updates yet for this supplement.
Be the first to share your experience!